Selected research
Industry Growth & Trends
Global Immobilized Lipase Industry Growth and Trends Forecast to 2032
Market perspective
The global Immobilized Lipase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Immobilized Lipase is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Immobilized Lipase is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Immobilized Lipase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Immobilized Lipase include Syncozymes, Yili Chuannig Biotechnology, Amicogen, ChiralVision, Novozymes, Beijing Global Biologicals and Qingdao Weilan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Immobilized Lipase market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Immobilized Lipase market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immobilized Lipase market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immobilized Lipase.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Immobilized Lipase market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Immobilized Lipase Market by Company
Syncozymes
Yili Chuannig Biotechnology
Amicogen
ChiralVision
Novozymes
Beijing Global Biologicals
Qingdao Weilan Bio
Immobilized Lipase Segment by Type
Encapsulation
Covalent Bonding
Adsorption
Cross-linking
Immobilized Lipase Segment by Application
Pharmaceuticals
Food
Chemicals
Others
Immobilized Lipase Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immobilized Lipase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immobilized Lipase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immobilized Lipase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immobilized Lipase manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Immobilized Lipase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Encapsulation
- Covalent Bonding
- Adsorption
- Cross-linking
Applications
- Pharmaceuticals
- Food
- Chemicals
- Others
Companies covered
- Syncozymes
- Yili Chuannig Biotechnology
- Amicogen
- ChiralVision
- Novozymes
- Beijing Global Biologicals
- Qingdao Weilan Bio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Immobilized Lipase Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Immobilized Lipase Sales Estimates and Forecasts (2021-2032)
- 1.3 Immobilized Lipase Market by Type
- 1.3.1 Encapsulation
- 1.3.2 Covalent Bonding
- 1.3.3 Adsorption
- 1.3.4 Cross-linking
- 1.4 Global Immobilized Lipase Market Size by Type
- 1.4.1 Global Immobilized Lipase Market Size Overview by Type (2021-2032)
- 1.4.2 Global Immobilized Lipase Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Immobilized Lipase Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Immobilized Lipase Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Immobilized Lipase Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Immobilized Lipase Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Immobilized Lipase Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Immobilized Lipase Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Immobilized Lipase Industry Trends
- 2.2 Immobilized Lipase Industry Drivers
- 2.3 Immobilized Lipase Industry Opportunities and Challenges
- 2.4 Immobilized Lipase Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Immobilized Lipase Revenue (2021-2026)
- 3.2 Global Top Players by Immobilized Lipase Sales (2021-2026)
- 3.3 Global Top Players by Immobilized Lipase Price (2021-2026)
- 3.4 Global Immobilized Lipase Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Immobilized Lipase Major Company Production Sites & Headquarters
- 3.6 Global Immobilized Lipase Company, Product Type & Application
- 3.7 Global Immobilized Lipase Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Immobilized Lipase Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Immobilized Lipase Players Market Share by Revenue in 2025
- 3.8.3 2025 Immobilized Lipase Tier 1, Tier 2, and Tier 3
4 Immobilized Lipase Regional Status and Outlook
- 4.1 Global Immobilized Lipase Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Immobilized Lipase Historic Market Size by Region
- 4.2.1 Global Immobilized Lipase Sales in Volume by Region (2021-2026)
- 4.2.2 Global Immobilized Lipase Sales in Value by Region (2021-2026)
- 4.2.3 Global Immobilized Lipase Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Immobilized Lipase Forecasted Market Size by Region
- 4.3.1 Global Immobilized Lipase Sales in Volume by Region (2027-2032)
- 4.3.2 Global Immobilized Lipase Sales in Value by Region (2027-2032)
- 4.3.3 Global Immobilized Lipase Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Immobilized Lipase by Application
- 5.1 Immobilized Lipase Market by Application
- 5.1.1 Pharmaceuticals
- 5.1.2 Food
- 5.1.3 Chemicals
- 5.1.4 Others
- 5.2 Global Immobilized Lipase Market Size by Application
- 5.2.1 Global Immobilized Lipase Market Size Overview by Application (2021-2032)
- 5.2.2 Global Immobilized Lipase Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Immobilized Lipase Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Immobilized Lipase Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Immobilized Lipase Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Immobilized Lipase Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Immobilized Lipase Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Immobilized Lipase Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Syncozymes
- 6.1.1 Syncozymes Company Information
- 6.1.2 Syncozymes Business Overview
- 6.1.3 Syncozymes Immobilized Lipase Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Syncozymes Immobilized Lipase Product Portfolio
- 6.1.5 Syncozymes Recent Developments
- 6.2 Yili Chuannig Biotechnology
- 6.2.1 Yili Chuannig Biotechnology Company Information
- 6.2.2 Yili Chuannig Biotechnology Business Overview
- 6.2.3 Yili Chuannig Biotechnology Immobilized Lipase Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Yili Chuannig Biotechnology Immobilized Lipase Product Portfolio
- 6.2.5 Yili Chuannig Biotechnology Recent Developments
- 6.3 Amicogen
- 6.3.1 Amicogen Company Information
- 6.3.2 Amicogen Business Overview
- 6.3.3 Amicogen Immobilized Lipase Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Amicogen Immobilized Lipase Product Portfolio
- 6.3.5 Amicogen Recent Developments
- 6.4 ChiralVision
- 6.4.1 ChiralVision Company Information
- 6.4.2 ChiralVision Business Overview
- 6.4.3 ChiralVision Immobilized Lipase Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 ChiralVision Immobilized Lipase Product Portfolio
- 6.4.5 ChiralVision Recent Developments
- 6.5 Novozymes
- 6.5.1 Novozymes Company Information
- 6.5.2 Novozymes Business Overview
- 6.5.3 Novozymes Immobilized Lipase Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Novozymes Immobilized Lipase Product Portfolio
- 6.5.5 Novozymes Recent Developments
- 6.6 Beijing Global Biologicals
- 6.6.1 Beijing Global Biologicals Company Information
- 6.6.2 Beijing Global Biologicals Business Overview
- 6.6.3 Beijing Global Biologicals Immobilized Lipase Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Beijing Global Biologicals Immobilized Lipase Product Portfolio
- 6.6.5 Beijing Global Biologicals Recent Developments
- 6.7 Qingdao Weilan Bio
- 6.7.1 Qingdao Weilan Bio Company Information
- 6.7.2 Qingdao Weilan Bio Business Overview
- 6.7.3 Qingdao Weilan Bio Immobilized Lipase Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Qingdao Weilan Bio Immobilized Lipase Product Portfolio
- 6.7.5 Qingdao Weilan Bio Recent Developments
7 North America by Country
- 7.1 North America Immobilized Lipase Sales by Country
- 7.1.1 North America Immobilized Lipase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Immobilized Lipase Sales by Country (2021-2026)
- 7.1.3 North America Immobilized Lipase Sales Forecast by Country (2027-2032)
- 7.2 North America Immobilized Lipase Market Size by Country
- 7.2.1 North America Immobilized Lipase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Immobilized Lipase Market Size by Country (2021-2026)
- 7.2.3 North America Immobilized Lipase Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Immobilized Lipase Sales by Country
- 8.1.1 Europe Immobilized Lipase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Immobilized Lipase Sales by Country (2021-2026)
- 8.1.3 Europe Immobilized Lipase Sales Forecast by Country (2027-2032)
- 8.2 Europe Immobilized Lipase Market Size by Country
- 8.2.1 Europe Immobilized Lipase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Immobilized Lipase Market Size by Country (2021-2026)
- 8.2.3 Europe Immobilized Lipase Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Immobilized Lipase Sales by Country
- 9.1.1 Asia-Pacific Immobilized Lipase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Immobilized Lipase Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Immobilized Lipase Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Immobilized Lipase Market Size by Country
- 9.2.1 Asia-Pacific Immobilized Lipase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Immobilized Lipase Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Immobilized Lipase Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Immobilized Lipase Sales by Country
- 10.1.1 South America Immobilized Lipase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Immobilized Lipase Sales by Country (2021-2026)
- 10.1.3 South America Immobilized Lipase Sales Forecast by Country (2027-2032)
- 10.2 South America Immobilized Lipase Market Size by Country
- 10.2.1 South America Immobilized Lipase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Immobilized Lipase Market Size by Country (2021-2026)
- 10.2.3 South America Immobilized Lipase Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Immobilized Lipase Sales by Country
- 11.1.1 Middle East and Africa Immobilized Lipase Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Immobilized Lipase Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Immobilized Lipase Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Immobilized Lipase Market Size by Country
- 11.2.1 Middle East and Africa Immobilized Lipase Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Immobilized Lipase Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Immobilized Lipase Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Immobilized Lipase Value Chain Analysis
- 12.1.1 Immobilized Lipase Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Immobilized Lipase Production Mode & Process
- 12.2 Immobilized Lipase Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Immobilized Lipase Distributors
- 12.2.3 Immobilized Lipase Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst